Therapeutic Effect of IL1β Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis.

Minjoo Yoo Sungkuk Cho Sunhye Shin Jung-Mi Kim Hyeon-Gyeong Park Sung Yoo Cho Yu Kyeong Hwang Dae Hwi Park

Published in: Tissue engineering and regenerative medicine (2021)

IL1β priming can endow constant therapeutic efficacy with TMSCs, which may contribute to improve bone density and maintain bone homeostasis in postmenopausal osteoporosis. Therefore, IL1β priming TMSCs can be a new therapeutic option for treating postmenopausal osteoporosis.

Keyphrases

bone mineral density
postmenopausal women
body composition
bone loss